Mallinckrodt plc Stock News

Mallinckrodt publishes findings from Phase 4 Acthar Gel study MNK

Mallinckrodt PLC (NYSE:MNK) shares rose 2.7% during trading on Monday . The stock traded as high as $3.96 and last traded at $3.76, approximately 147,218 shares were traded during trading. A decline o

Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today announced the publication of findings from its randomized, placebo-controlled, double-blind Phase 4 study to assess the safety a

The "Opioid Induced Constipation Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.

Full Year 2019 Silence Therapeutics PLC Earnings Call

Final results for the year ended 31 December 2019 April 14, 2020 LONDON, Silence Therapeutics, PLC (LON: SLN) (“Silence” or “the Company”) a leader in the discovery,.

Man Group plc purchased a new stake in shares of Mallinckrodt PLC (NYSE:MNK) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purc

Mallinckrodt (NYSE:MNK) was upgraded by equities researchers at ValuEngine from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Tuesday, ValuEngine r

Credit Suisse AG lessened its stake in shares of Mallinckrodt PLC (NYSE:MNK) by 98.2% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 11,181 shares of the comp

Mallinckrodt PLC (NYSE:MNK)’s share price gapped up before the market opened on Wednesday . The stock had previously closed at $2.21, but opened at $2.09. Mallinckrodt shares last traded at $2.60, w

The "Opioid Induced Constipation Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.

Cubist Systematic Strategies LLC cut its holdings in shares of Mallinckrodt PLC (NYSE:MNK) by 28.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange

Mallinckrodt (MNK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Mallinckrodt (MNK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.